Atlas Trials

Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes

Clinical trial NCT01324505 · COMPLETED

Trial details

NCT number
NCT01324505
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 2
Start date
2011-03-01
Primary completion
2012-01-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.